RNA sequencing of esophageal adenocarcinomas identifies novel fusion transcripts, including NPC1-MELK, arising from a complex chromosomal rearrangement.

Background: Studies of chromosomal rearrangements and fusion transcripts have elucidated mechanisms of tumorigenesis and led to targeted cancer therapies. This study was aimed at identifying novel fusion transcripts in esophageal adenocarcinoma (EAC).Methods: To identify new fusion transcripts assoc...

Descripción completa

Detalles Bibliográficos
Publicado en:Cancer (0008543X) Vol. 123; no. 20; pp. 3916 - 3926
Autores principales: Wang, Zhixiong, Cheng, Yulan, Abraham, John M., Yan, Rong, Liu, Xi, Chen, Wei, Ibrahim, Sariat, Schroth, Gary P., Ke, Xiquan, He, Yulong, Meltzer, Stephen J.
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell Oct2017
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=125461669&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 125461669
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        0008543X
        23I
      jtl: Cancer (0008543X)
      issn: 0008543X
      maglogo: Y
    pubinfo:
      dt: Oct2017
      vid: 123
      iid: 20
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        125461669
        125461669
        NLM28640357
        125461669
        10.1002/cncr.30837
        NLM28640357
        125461669
      ppf: 3916
      ppct: 10
      formats:
      tig:
        atl: RNA sequencing of esophageal adenocarcinomas identifies novel fusion transcripts, including NPC1-MELK, arising from a complex chromosomal rearrangement.
      aug:
        au:
          Wang, Zhixiong
          Cheng, Yulan
          Abraham, John M.
          Yan, Rong
          Liu, Xi
          Chen, Wei
          Ibrahim, Sariat
          Schroth, Gary P.
          Ke, Xiquan
          He, Yulong
          Meltzer, Stephen J.
        affil: Department of Gastrointestinal Surgery, First Affiliated Hospital of Sun Yat‐Sen University, Guangzhou China
      sug:
        subj:
          Adenocarcinoma
          Proteins
          Esophageal Neoplasms
          Genes
          RNA Metabolism
          Receptors, Cell Surface
          Phosphotransferases
          Membrane Glycoproteins
          Adult
          Middle Age
          Female
          Sequence Analysis
          Aged
          Carrier Proteins
          Peptide Hydrolases
          Case Control Studies
          Cell Line, Tumor
          Male
          Calcium Binding Proteins
          Reverse Transcriptase Polymerase Chain Reaction
          Transferases
          Aged, 80 and Over
          Human
          Funding Source
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Aged, 80 & over
          Female
          Male
      ab: Background: Studies of chromosomal rearrangements and fusion transcripts have elucidated mechanisms of tumorigenesis and led to targeted cancer therapies. This study was aimed at identifying novel fusion transcripts in esophageal adenocarcinoma (EAC).Methods: To identify new fusion transcripts associated with EAC, targeted RNA sequencing and polymerase chain reaction (PCR) verification were performed in 40 EACs and matched nonmalignant specimens from the same patients. Genomic PCR and Sanger sequencing were performed to find the breakpoint of fusion genes.Results: Five novel in-frame fusion transcripts were identified and verified in 40 EACs and in a validation cohort of 15 additional EACs (55 patients in all): fibroblast growth factor receptor 2 (FGFR2)-GRB2-associated binding protein 2 (GAB2) in 2 of 55 or 3.6%, Niemann-Pick C1 (NPC1)-maternal embryonic leucine zipper kinase (MELK) in 2 of 55 or 3.6%, ubiquitin-specific peptidase 54 (USP54)-calcium/calmodulin dependent protein kinase II γ (CAMK2G) in 2 of 55 or 3.6%, megakaryoblastic leukemia (translocation) 1 (MKL1)-fibulin 1 (FBLN1) in 1 of 55 or 1.8%, and CCR4-NOT transcription complex subunit 2 (CNOT2)-chromosome 12 open reading frame 49 (C12orf49) in 1 of 55 or 1.8%. A genomic analysis indicated that NPC1-MELK arose from a complex interchromosomal translocation event involving chromosomes 18, 3, and 9 with 3 rearrangement points, and this was consistent with chromoplexy.Conclusions: These data indicate that fusion transcripts occur at a stable frequency in EAC. Furthermore, our results indicate that chromoplexy is an underlying mechanism that generates fusion transcripts in EAC. These and other fusion transcripts merit further study as diagnostic markers and potential therapeutic targets in EAC. Cancer 2017;123:3916-24. © 2017 American Cancer Society.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N